TIMP3 and cancer: Conversely, decreased TIMP3 expression has been observed in a variety of malignancies and has been correlated with aggressiveness in cancers arising in the thyroid, breast, prostate and lung, which supports a role for TIMP3 as a tumor suppressor via its ability to inhibit MMPs [9–13].